Exelixis

Exelixis is a biotechnology company in the development stage, dedicated to discovering and developing novel small-molecule therapies for treating cancer and other serious diseases. The company is leveraging its fully integrated drug discovery platform to drive the growth of its development pipeline, which primarily focuses on cancer. Currently, Exelixis has a broad product portfolio that includes investigational compounds in Phase 2 and Phase 1 clinical development.